A behavioural test battery to investigate tic-like symptoms, stereotypies, attentional capabilities, and spontaneous locomotion in different mouse strains

Behavioural Brain Research

Volumn 267, Issue , 2014, Pages 95-105

  Proietti Onori, Martina ^a   Ceci, Chiara ^a   Laviola, Giovanni ^a   Macri, Simone ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Amphetamine; Animal model; DOI; Perseverative responding; Stereotypies; Tourette's syndrome

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; AMPHETAMINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; SEROTONIN AGONIST;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; BIOZZI MOUSE; C57BL 6 MOUSE; CD-1 MOUSE; CIRCADIAN RHYTHM; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL BEHAVIORAL TEST; HEAD TWITCH; HOME-CAGE ACTIVITY TEST; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NEUROCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEREOTYPY; STRAIN DIFFERENCE; SWISS JAMES LAMBERT MOUSE; TIC; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; DYSKINESIA, DRUG-INDUCED; GILLES DE LA TOURETTE SYNDROME; INBRED MOUSE STRAIN; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGIC TEST; SPECIES DIFFERENCE; TICS;

AMPHETAMINE; AMPHETAMINES; ANIMALS; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; MALE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOTOR ACTIVITY; PSYCHOLOGICAL TESTS; SEROTONIN RECEPTOR AGONISTS; SPECIES SPECIFICITY; STEREOTYPED BEHAVIOR; TICS; TOURETTE SYNDROME;

EID: 84897551212     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.023     Document Type: Article

References (86)

1. Kerr T.M., Muller C.L., Miah M., Jetter C.S., Pfeiffer R., Shah C., et al. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism 2013, 4:35.
2. Garner J.P., Thogerson C.M., Dufour B.D., Wurbel H., Murray J.D., Mench J.A. Reverse-translational biomarker validation of abnormal repetitive behaviors in mice: an illustration of the 4P's modeling approach. Behav Brain Res 2011, 219:189-196.
3. Felling R.J., Singer H.S. Neurobiology of Tourette syndrome: current status and need for further investigation. J Neurosci 2011, 31:12387-12395.
4. Leckman J.F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. J Child Adolesc Psychopharmacol 2010, 20:237-247.
5. Health NIoM The National Institute of Mental Health Strategic Plan 2008.
6. Leckman J.F., Bloch M.H., Scahill L., King R.A. Tourette syndrome: the self under siege. J Child Neurol 2006, 21:642-649.
7. Sheppard D.M., Bradshaw J.L., Purcell R., Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?. Clin Psychol Rev 1999, 19:531-552.
8. Leckman J.F., Walker D.E., Cohen D.J. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993, 150:98-102.
9. Swerdlow N.R. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev 2013, 37:1150-1156.
10. Leisman G., Melillo R., Carrick F.R. Clinical motor and cognitive neurobehavioral relationships in the Basal Ganglia. Basal Ganglia - an integrative view 2012, 1-30. InTech. F.A. Barrios, C. Bauer (Eds.).
11. Wurbel H., Stauffacher M. Prevention of stereotypy in laboratory mice: effects on stress physiology and behaviour. Physiol Behav 1996, 59:1163-1170.
12. Wurbel H., Stauffacher M., vonHolst D. Stereotypies in laboratory mice - Quantitative and qualitative description of the ontogeny of 'wire-gnawing' and 'jumping' in Zur:ICR and Zur:ICR nu. Ethology 1996, 102:371-385.
13. He M., Shippenberg T.S. Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. J Pharmacol Exp Ther 2000, 293:121-127.
14. Colacicco G., Welzl H., Lipp H.P., Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav Brain Res 2002, 132:95-102.
15. Bullock A.E., Slobe B.S., Vazquez V., Collins A.C. Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav Neurosci 1997, 111:1353-1360.
16. Willott J.F., Tanner L., O'Steen J., Johnson K.R., Bogue M.A., Gagnon L. Acoustic startle and prepulse inhibition in 40 inbred strains of mice. Behav Neurosci 2003, 117:716-727.
17. Hoffman K.L., Hornig M., Yaddanapudi K., Jabado O., Lipkin W.I. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci 2004, 24:1780-1791.
18. Yaddanapudi K., Hornig M., Serge R., De Miranda J., Baghban A., Villar G., et al. Passive transfer of Streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 2010, 15:712-726.
19. Church A.J., Dale R.C., Lees A.J., Giovannoni G., Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosur Psychiatry 2003, 74:602-607.
20. Garvey M.A., Giedd J., Swedo S.E. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol 1998, 13:413-423.
21. Amor S., Smith P.A., Hart B., Baker D. Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 2005, 165:1-10.
22. Baker D., O'Neill J.K., Gschmeissner S.E., Wilcox C.E., Butter C., Turk J.L. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 1990, 28:261-270.
23. Canal C.E., Morgan D. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 2012, 4:556-576.
24. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 2000, 20:4320-4324.
25. Macrì S., Biamonte F., Romano E., Marino R., Keller F., Laviola G. Perseverative responding and neuroanatomical alterations in adult heterozygous reeler mice are mitigated by neonatal estrogen administration. Psychoneuroendocrinology 2010, 35:1374-1387.
26. Garner J.P., Thogerson C.M., Wurbel H., Murray J.D., Mench J.A. Animal neuropsychology: validation of the intra-dimensional extra-dimensional set shifting task for mice. Behav Brain Res 2006, 173:53-61.
27. Laviola G., Adriani W., Gaudino C., Marino R., Keller F. Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice. Psychopharmacology (Berl) 2006, 187:331-344.
28. Egashira N., Shirakawa A., Okuno R., Mishima K., Iwasaki K., Oishi R., et al. Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice. Pharmacol Biochem Behav 2011, 99:52-58.
29. Dell'Omo G., Vannoni E., Vyssotski A.L., Di Bari M.A., Nonno R., Agrimi U., et al. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 2002, 16:735-742.
30. Macrì S., Ceci C., Altabella L., Canese R., Laviola G. The Directive 2010/63/EU on animal experimentation may skew the conclusions of pharmacological and behavioural studies. Sci Rep 2013, 3:2380.
31. De Filippis B., Ricceri L., Laviola G. Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome. Genes Brain Behav 2010, 9:213-223.
32. Macrì S., Granstrem O., Shumilina M., Antunes Gomes dos Santos F.J., Berry A., Saso L., et al. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Horm Behav 2009, 56:391-398.
33. Cabib S., Orsini C., Le Moal M., Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 2000, 289:463-465.
34. Irie F., Badie-Mahdavi H., Yamaguchi Y. Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad Sci USA 2012, 109:5052-5056.
35. Joyce E.M., Iversen S.D. Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition. Psychopharmacology (Berl) 1984, 83:363-366.
36. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998, 24:285-301.
37. Willins D.L., Meltzer H.Y. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 1997, 282:699-706.
38. Garner J.P. Stereotypies and other abnormal repetitive behaviors: potential impact on validity, reliability, and replicability of scientific outcomes. ILAR J 2005, 46:106-117.
39. Gross A.N., Richter S.H., Engel A.K., Wurbel H. Cage-induced stereotypies, perseveration and the effects of environmental enrichment in laboratory mice. Behav Brain Res 2012, 234:61-68.
40. Garner J.P., Mason G.J. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav Brain Res 2002, 136:83-92.
41. Laviola G., Adriani W., Rea M., Aloe L., Alleva E. Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology (Berl) 2004, 175:196-205.
42. Laviola G., Dell'Omo G., Chiarotti F., Bignami G. d-Amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. Behav Neurosci 1994, 108:514-524.
43. Lewis M.H., Tanimura Y., Lee L.W., Bodfish J.W. Animal models of restricted repetitive behavior in autism. Behav Brain Res 2007, 176:66-74.
44. Crider A. Perseveration in schizophrenia. Schizophr Bull 1997, 23:63-74.
45. van der Staay F.J. Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev 2006, 52:131-159.
46. van der Staay F.J., Arndt S.S., Nordquist R.E. Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct 2009, 5:11.
47. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiatry 1986, 10:677-690.
48. Baumann M.H., Rothman R.B. Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats. Neuropharmacology 1996, 35:295-301.
49. Dursun S.M., Handley S.L. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Br J Pharmacol 1993, 109:1046-1052.
50. Yao Y., Ma H.W., Lu Y., Dai X.M. Roles of fluoxetine and haloperidol in mouse models of DOI-induced head twitch response. Zhongguo Dang Dai Er Ke Za Zhi 2007, 9:469-472.
51. Hayslett R.L., Tizabi Y. Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome. Pharmacol Biochem Behav 2005, 81:879-886.
52. Mestre T.A., Zurowski M., Fox S.H. 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. Expert Opin Investig Drugs 2013, 22:411-421.
53. Stamenkovic M., Schindler S.D., Aschauer H.N., De Zwaan M., Willinger U., Resinger E., et al. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol 2000, 15:23-28.
54. Wong D.F., Brasic J.R., Singer H.S., Schretlen D.J., Kuwabara H., Zhou Y., et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 2008, 33:1239-1251.
55. Behen M., Chugani H.T., Juhasz C., Helder E., Ho A., Maqbool M., et al. Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome. Mov Disord 2007, 22:2256-2262.
56. Steeves T.D., Fox S.H. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 2008, 172:495-513.
57. Haugbol S., Pinborg L.H., Regeur L., Hansen E.S., Bolwig T.G., Nielsen F.A., et al. Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 2007, 10:245-252.
58. Hoekstra P.J., Anderson G.M., Limburg P.C., Korf J., Kallenberg C.G., Minderaa R.B. Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 2004, 61:886-898.
59. Lawson-Yuen A., Saldivar J.S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008, 16:614-618.
60. Mulle J.G., Warren S.T. Genomic tics in Tourette syndrome. Biol Psychiatry 2012, 71:390-391.
61. O'Rourke J.A., Scharf J.M., Yu D., Pauls D.L. The genetics of Tourette syndrome: a review. J Psychosom Res 2009, 67:533-545.
62. State M.W. The genetics of Tourette disorder. Curr Opin Genet Dev 2011, 21:302-309.
63. Paschou P. The genetic basis of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1026-1039.
64. Motlagh M.G., Katsovich L., Thompson N., Lin H.Q., Kim Y.S., Scahill L., et al. Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur Child Adolesc Psychiatry 2010, 19:755-764.
65. Leckman J.F., Dolnansky E.S., Hardin M.T., Clubb M., Walkup J.T., Stevenson J., et al. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 1990, 29:220-226.
66. Macrì S., Proietti Onori M., Laviola G. Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1085-1100.
67. Conelea C.A., Woods D.W. The influence of contextual factors on tic expression in Tourette's syndrome: a review. J Psychos Res 2008, 65:487-496.
68. Hoekstra P.J., Dietrich A., Edwards M.J., Elamin I., Martino D. Environmental factors in Tourette syndrome. Neurosci Biobehav Rev 2012, 37:1040-1049.
69. Lin H., Katsovich L., Ghebremichael M., Findley D.B., Grantz H., Lombroso P.J., et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry Allied Disciplines 2007, 48:157-166.
70. Martino D., Chiarotti F., Buttiglione M., Cardona F., Creti R., Nardocci N., et al. The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol 2011, 53:951-957.
71. Hornig M., Lipkin W.I. Immune-mediated animal models of Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1120-1138.
72. Campbell K.M., McGrath M.J., Burton F.H. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion. Brain Res 1999, 833:216-224.
73. Deminiere J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., et al. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res 1992, 586:135-139.
74. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
75. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
76. Gilbert D.L., Bansal A.S., Sethuraman G., Sallee F.R., Zhang J., Lipps T., et al. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord 2004, 19:416-425.
77. Moy S.S., Nadler J.J., Young N.B., Nonneman R.J., Segall S.K., Andrade G.M., et al. Social approach and repetitive behavior in eleven inbred mouse strains. Behav Brain Res 2008, 191:118-129.
78. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007, 176:4-20.
79. Dellu F., Contarino A., Simon H., Koob G.F., Gold L.H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 2000, 73:31-48.
80. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res 1996, 77:23-43.
81. Bardo M.T., Neisewander J.L., Pierce R.C. Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs. Pharmacol Biochem Behav 1989, 32:683-689.
82. Orsini C., Bonito-Oliva A., Conversi D., Cabib S. Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology (Berl) 2005, 181:327-336.
83. Thomsen M., Ralph R.J., Caine S.B. Psychomotor stimulation by dopamine D(1)-like but not D(2)-like agonists in most mouse strains. Exp Clin Psychopharmacol 2011, 19:342-360.
84. Sugimoto Y., Kajiwara Y., Hirano K., Yamada S., Tagawa N., Kobayashi Y., et al. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol 2008, 592:116-122.
85. Sugimoto Y., Yamamoto M., Tagawa N., Kobayashi Y., Mitsui-Saitoh K., Hotta Y., et al. Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems. Eur J Pharmacol 2011, 672:121-125.
86. Mhyre T.R., Chesler E.J., Thiruchelvam M., Lungu C., Cory-Slechta D.A., Fry J.D., et al. Heritability, correlations and in silico mapping of locomotor behavior and neurochemistry in inbred strains of mice. Genes Brain Behav 2005, 4:209-228.